ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,830 | -97.9% | 35,300 | -86.9% | 0.00% | -100.0% |
| Q3 2023 | $1,847,759 | -60.8% | 269,746 | -40.6% | 0.01% | -65.9% |
| Q2 2023 | $4,712,242 | +2.1% | 454,411 | -20.3% | 0.04% | -6.8% |
| Q1 2023 | $4,613,264 | -28.9% | 570,243 | +38.3% | 0.04% | -18.5% |
| Q4 2022 | $6,492,749 | +3.1% | 412,238 | +3.0% | 0.05% | +1.9% |
| Q3 2022 | $6,300,000 | +3.4% | 400,160 | -8.3% | 0.05% | -10.2% |
| Q2 2022 | $6,090,000 | -25.3% | 436,260 | -7.7% | 0.06% | -19.2% |
| Q1 2022 | $8,150,000 | +14.3% | 472,760 | -3.6% | 0.07% | +12.3% |
| Q4 2021 | $7,131,000 | -22.7% | 490,460 | -4.4% | 0.06% | -31.6% |
| Q3 2021 | $9,231,000 | +106.7% | 512,875 | +101.6% | 0.10% | +102.1% |
| Q2 2021 | $4,466,000 | -51.8% | 254,344 | -30.8% | 0.05% | -58.4% |
| Q1 2021 | $9,258,000 | +366.4% | 367,392 | +19.7% | 0.11% | +318.5% |
| Q4 2020 | $1,985,000 | +209.7% | 306,900 | +23.2% | 0.03% | +125.0% |
| Q3 2020 | $641,000 | +0.8% | 249,200 | -36.5% | 0.01% | +33.3% |
| Q2 2020 | $636,000 | +2665.2% | 392,200 | +1661.4% | 0.01% | +800.0% |
| Q1 2020 | $23,000 | -97.6% | 22,266 | -65.7% | 0.00% | -97.6% |
| Q3 2018 | $944,000 | -27.4% | 65,000 | -0.2% | 0.04% | -40.0% |
| Q2 2018 | $1,300,000 | +61.7% | 65,100 | +42.1% | 0.07% | +16.7% |
| Q1 2018 | $804,000 | -25.9% | 45,828 | +14.6% | 0.06% | -46.4% |
| Q2 2017 | $1,085,000 | -24.7% | 40,000 | -17.1% | 0.11% | -22.2% |
| Q1 2017 | $1,440,000 | – | 48,277 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 12,988,134 | $14,286,947 | 10.20% |
| Stonepine Capital Management, LLC | 1,927,446 | $2,120,191 | 1.95% |
| Aldebaran Capital, LLC | 858,152 | $943,967 | 0.88% |
| Acuitas Investments, LLC | 464,120 | $510,532 | 0.27% |
| Trium Capital LLP | 1,892,050 | $2,081 | 0.26% |
| Aisling Capital Management LP | 434,455 | $477,901 | 0.21% |
| Samsara BioCapital, LLC | 696,171 | $765,788 | 0.16% |
| Deuterium Capital Management, LLC | 72,091 | $79,300 | 0.13% |
| Bain Capital Life Sciences Investors, LLC | 1,000,000 | $1,100,000 | 0.12% |
| Rock Springs Capital Management LP | 2,753,495 | $3,028,845 | 0.09% |